Revolutionizing the treatment of bacterial disease

all companies
milestones

Founded 2015

Partnered 2017​

Team

Paul Garofolo

Dave Ousterout

Board

Stuart Peterson

Austin Walne (observer)

LEAD INVESTOR
category
Infectious

Designing and developing powerful antimicrobials that avoid currently known antibiotic resistance mechanisms while leaving non-target bacteria unharmed

No items found.